Symbol: |
Psors1c2 |
Name: |
psoriasis susceptibility 1 candidate 2 |
RGD ID: |
1591981 |
Description: |
Orthologous to human PSORS1C2 (psoriasis susceptibility 1 candidate 2); INTERACTS WITH 1-naphthyl isothiocyanate; alpha-Zearalanol; bisphenol A. |
Type: |
protein-coding
|
RefSeq Status: |
VALIDATED |
Previously known as: |
LOC686254; Pcg; psoriasis susceptibility 1 candidate 2 (human); similar to Psoriasis susceptibility 1 candidate gene 2 protein homolog precursor (SPR1 protein); Spr1 |
RGD Orthologs |
|
Alliance Orthologs |
|
More Info |
more info ...
|
More Info |
|
Latest Assembly: |
GRCr8 - GRCr8 Assembly |
Position: |
Rat Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCr8 | 20 | 3,206,886 - 3,208,307 (-) | NCBI | | GRCr8 | | | mRatBN7.2 | 20 | 3,202,178 - 3,203,599 (-) | NCBI | mRatBN7.2 | mRatBN7.2 | | | mRatBN7.2 Ensembl | 20 | 3,202,174 - 3,203,599 (-) | Ensembl | | mRatBN7.2 Ensembl | | | UTH_Rnor_SHR_Utx | 20 | 3,263,916 - 3,264,904 (-) | NCBI | Rnor_SHR | UTH_Rnor_SHR_Utx | | | UTH_Rnor_SHRSP_BbbUtx_1.0 | 20 | 3,268,887 - 3,269,875 (-) | NCBI | Rnor_SHRSP | UTH_Rnor_SHRSP_BbbUtx_1.0 | | | UTH_Rnor_WKY_Bbb_1.0 | 20 | 3,293,084 - 3,294,073 (-) | NCBI | Rnor_WKY | UTH_Rnor_WKY_Bbb_1.0 | | | Rnor_6.0 | 20 | 3,727,817 - 3,728,805 (-) | NCBI | Rnor6.0 | Rnor_6.0 | rn6 | Rnor6.0 | Rnor_6.0 Ensembl | 20 | 3,727,419 - 3,728,844 (-) | Ensembl | Rnor6.0 | | rn6 | Rnor6.0 | Rnor_5.0 | 20 | 5,815,020 - 5,816,008 (-) | NCBI | Rnor5.0 | Rnor_5.0 | rn5 | Rnor5.0 | Celera | 20 | 629,735 - 630,723 (-) | NCBI | | Celera | | | Cytogenetic Map | 20 | p12 | NCBI | | | | |
|
JBrowse: |
View Region in Genome Browser (JBrowse)
|
Model |
|
Psors1c2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1623241 | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of PSORS1C2 mRNA | CTD | PMID:22206623 | Psors1c2 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of PSORS1C2 mRNA | CTD | PMID:30723492 | Psors1c2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:1349813 | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSORS1C2 mRNA | CTD | PMID:23146750 | Psors1c2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1349813 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PSORS1C2 mRNA | CTD | PMID:23152189 | Psors1c2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1623241 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PSORS1C2 mRNA | CTD | PMID:21570461 | Psors1c2 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1349813 | 6480464 | Lactic Acid results in decreased expression of PSORS1C2 mRNA | CTD | PMID:30851411 | Psors1c2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | RGD:1623241 | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ... | CTD | PMID:37567420 | Psors1c2 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PSORS1C2 mRNA | CTD | PMID:35163327 | Psors1c2 | Rat | alpha-Zearalanol | decreases expression | EXP | | 6480464 | Zeranol results in decreased expression of PSORS1C2 mRNA | CTD | PMID:35163327 | Psors1c2 | Rat | arsane | multiple interactions | ISO | RGD:1349813 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PSORS1C2 more ... | CTD | PMID:32525701 | Psors1c2 | Rat | arsenic atom | multiple interactions | ISO | RGD:1349813 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PSORS1C2 more ... | CTD | PMID:32525701 | Psors1c2 | Rat | benzo[a]pyrene | increases expression | ISO | RGD:1623241 | 6480464 | Benzo(a)pyrene results in increased expression of PSORS1C2 mRNA | CTD | PMID:25908611 | Psors1c2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PSORS1C2 mRNA | CTD | PMID:25181051 | Psors1c2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PSORS1C2 mRNA | CTD | PMID:30816183|PMID:32528016 | Psors1c2 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of PSORS1C2 gene | CTD | PMID:28505145 | Psors1c2 | Rat | cisplatin | decreases expression | ISO | RGD:1349813 | 6480464 | Cisplatin results in decreased expression of PSORS1C2 mRNA | CTD | PMID:27392435 | Psors1c2 | Rat | cisplatin | multiple interactions | ISO | RGD:1349813 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of PSORS1C2 mRNA | CTD | PMID:27392435 | Psors1c2 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PSORS1C2 mRNA | CTD | PMID:26033743 | Psors1c2 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PSORS1C2 mRNA | CTD | PMID:26033743 | Psors1c2 | Rat | D-glucose | multiple interactions | ISO | RGD:1623241 | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ... | CTD | PMID:37567420 | Psors1c2 | Rat | fructose | multiple interactions | ISO | RGD:1623241 | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ... | CTD | PMID:37567420 | Psors1c2 | Rat | glucose | multiple interactions | ISO | RGD:1623241 | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ... | CTD | PMID:37567420 | Psors1c2 | Rat | herbicide | multiple interactions | ISO | RGD:1623241 | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ... | CTD | PMID:37567420 | Psors1c2 | Rat | lead diacetate | decreases expression | ISO | RGD:1623241 | 6480464 | lead acetate results in decreased expression of PSORS1C2 mRNA | CTD | PMID:22609695 | Psors1c2 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PSORS1C2 mRNA | CTD | PMID:35163327 | Psors1c2 | Rat | pioglitazone | multiple interactions | ISO | RGD:1623241 | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of PSORS1C2 mRNA | CTD | PMID:27935865 | Psors1c2 | Rat | rac-lactic acid | decreases expression | ISO | RGD:1349813 | 6480464 | Lactic Acid results in decreased expression of PSORS1C2 mRNA | CTD | PMID:30851411 | Psors1c2 | Rat | resveratrol | multiple interactions | ISO | RGD:1349813 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of PSORS1C2 mRNA | CTD | PMID:23557933 | Psors1c2 | Rat | silver atom | increases expression | ISO | RGD:1623241 | 6480464 | Silver results in increased expression of PSORS1C2 mRNA | CTD | PMID:27131904 | Psors1c2 | Rat | silver(0) | increases expression | ISO | RGD:1623241 | 6480464 | Silver results in increased expression of PSORS1C2 mRNA | CTD | PMID:27131904 | Psors1c2 | Rat | sodium arsenate | multiple interactions | ISO | RGD:1349813 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PSORS1C2 more ... | CTD | PMID:32525701 | Psors1c2 | Rat | titanium dioxide | increases expression | ISO | RGD:1623241 | 6480464 | titanium dioxide results in increased expression of PSORS1C2 mRNA | CTD | PMID:35295148 | Psors1c2 | Rat | XL147 | multiple interactions | ISO | RGD:1623241 | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PSORS1C2 mRNA | CTD | PMID:27935865 |
Psors1c2 (Rattus norvegicus - Norway rat) |
Rat Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCr8 | 20 | 3,206,886 - 3,208,307 (-) | NCBI | | GRCr8 | | | mRatBN7.2 | 20 | 3,202,178 - 3,203,599 (-) | NCBI | mRatBN7.2 | mRatBN7.2 | | | mRatBN7.2 Ensembl | 20 | 3,202,174 - 3,203,599 (-) | Ensembl | | mRatBN7.2 Ensembl | | | UTH_Rnor_SHR_Utx | 20 | 3,263,916 - 3,264,904 (-) | NCBI | Rnor_SHR | UTH_Rnor_SHR_Utx | | | UTH_Rnor_SHRSP_BbbUtx_1.0 | 20 | 3,268,887 - 3,269,875 (-) | NCBI | Rnor_SHRSP | UTH_Rnor_SHRSP_BbbUtx_1.0 | | | UTH_Rnor_WKY_Bbb_1.0 | 20 | 3,293,084 - 3,294,073 (-) | NCBI | Rnor_WKY | UTH_Rnor_WKY_Bbb_1.0 | | | Rnor_6.0 | 20 | 3,727,817 - 3,728,805 (-) | NCBI | Rnor6.0 | Rnor_6.0 | rn6 | Rnor6.0 | Rnor_6.0 Ensembl | 20 | 3,727,419 - 3,728,844 (-) | Ensembl | Rnor6.0 | | rn6 | Rnor6.0 | Rnor_5.0 | 20 | 5,815,020 - 5,816,008 (-) | NCBI | Rnor5.0 | Rnor_5.0 | rn5 | Rnor5.0 | Celera | 20 | 629,735 - 630,723 (-) | NCBI | | Celera | | | Cytogenetic Map | 20 | p12 | NCBI | | | | |
|
PSORS1C2 (Homo sapiens - human) |
Human Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCh38 | 6 | 31,137,534 - 31,139,066 (-) | NCBI | GRCh38 | GRCh38 | hg38 | GRCh38 | GRCh38.p14 Ensembl | 6 | 31,137,534 - 31,139,066 (-) | Ensembl | GRCh38 | | hg38 | GRCh38 | GRCh37 | 6 | 31,105,311 - 31,106,843 (-) | NCBI | GRCh37 | GRCh37 | hg19 | GRCh37 | Build 36 | 6 | 31,213,290 - 31,215,106 (-) | NCBI | NCBI36 | Build 36 | hg18 | NCBI36 | Build 34 | 6 | 31,213,289 - 31,215,097 | NCBI | | | | | Celera | 6 | 32,705,537 - 32,707,353 (-) | NCBI | | Celera | | | Cytogenetic Map | 6 | p21.33 | NCBI | | | | | HuRef | 6 | 30,907,791 - 30,909,607 (-) | NCBI | | HuRef | | | CHM1_1 | 6 | 31,107,395 - 31,109,211 (-) | NCBI | | CHM1_1 | | | T2T-CHM13v2.0 | 6 | 31,005,228 - 31,006,760 (-) | NCBI | | T2T-CHM13v2.0 | | |
|
Psors1c2 (Mus musculus - house mouse) |
Mouse Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCm39 | 17 | 35,842,462 - 35,845,544 (+) | NCBI | GRCm39 | GRCm39 | mm39 | | GRCm39 Ensembl | 17 | 35,844,098 - 35,845,544 (+) | Ensembl | | GRCm39 Ensembl | | | GRCm38 | 17 | 35,533,201 - 35,534,647 (+) | NCBI | GRCm38 | GRCm38 | mm10 | GRCm38 | GRCm38.p6 Ensembl | 17 | 35,533,201 - 35,534,647 (+) | Ensembl | GRCm38 | | mm10 | GRCm38 | MGSCv37 | 17 | 35,670,146 - 35,671,592 (+) | NCBI | GRCm37 | MGSCv37 | mm9 | NCBIm37 | MGSCv36 | 17 | 35,141,322 - 35,142,698 (+) | NCBI | | MGSCv36 | mm8 | | Celera | 17 | 39,048,039 - 39,049,485 (+) | NCBI | | Celera | | | Cytogenetic Map | 17 | B1 | NCBI | | | | | cM Map | 17 | 18.7 | NCBI | | | | |
|
Psors1c2 (Chinchilla lanigera - long-tailed chinchilla) |
Chinchilla Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
ChiLan1.0 Ensembl | NW_004955583 | 974,890 - 976,777 (-) | Ensembl | ChiLan1.0 | | | | ChiLan1.0 | NW_004955583 | 975,037 - 977,944 (-) | NCBI | ChiLan1.0 | ChiLan1.0 | | |
|
PSORS1C2 (Pan paniscus - bonobo/pygmy chimpanzee) |
Bonobo Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
NHGRI_mPanPan1-v2 | 5 | 45,699,553 - 45,700,940 (-) | NCBI | | NHGRI_mPanPan1-v2 | | | NHGRI_mPanPan1 | 6 | 41,662,768 - 41,664,689 (-) | NCBI | | NHGRI_mPanPan1 | | | Mhudiblu_PPA_v0 | 6 | 30,883,467 - 30,888,231 (-) | NCBI | Mhudiblu_PPA_v0 | Mhudiblu_PPA_v0 | panPan3 | | PanPan1.1 | 6 | 31,748,923 - 31,750,739 (-) | NCBI | panpan1.1 | PanPan1.1 | panPan2 | | PanPan1.1 Ensembl | 6 | 31,748,923 - 31,750,739 (-) | Ensembl | panpan1.1 | | panPan2 | |
|
CCHCR1 (Canis lupus familiaris - dog) |
Dog Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
CanFam3.1 | 12 | 837,986 - 840,490 (-) | NCBI | CanFam3.1 | CanFam3.1 | canFam3 | CanFam3.1 | CanFam3.1 Ensembl | 12 | 837,993 - 854,978 (-) | Ensembl | CanFam3.1 | | canFam3 | CanFam3.1 | Dog10K_Boxer_Tasha | 12 | 975,622 - 978,107 (-) | NCBI | | Dog10K_Boxer_Tasha | | | ROS_Cfam_1.0 | 12 | 111,814 - 114,270 (+) | NCBI | | ROS_Cfam_1.0 | | | ROS_Cfam_1.0 Ensembl | 12 | 97,456 - 114,270 (+) | Ensembl | | ROS_Cfam_1.0 Ensembl | | | UMICH_Zoey_3.1 | 12 | 841,841 - 844,312 (-) | NCBI | | UMICH_Zoey_3.1 | | | UNSW_CanFamBas_1.0 | 12 | 910,045 - 912,527 (-) | NCBI | | UNSW_CanFamBas_1.0 | | | UU_Cfam_GSD_1.0 | 12 | 977,620 - 980,122 (-) | NCBI | | UU_Cfam_GSD_1.0 | | |
|
Psors1c2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
PSORS1C2 (Sus scrofa - pig) |
Pig Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
Sscrofa11.1 Ensembl | 7 | 23,540,344 - 23,542,930 (-) | Ensembl | Sscrofa11.1 | | susScr11 | Sscrofa11.1 | Sscrofa11.1 | 7 | 23,540,341 - 23,543,136 (-) | NCBI | Sscrofa11.1 | Sscrofa11.1 | susScr11 | Sscrofa11.1 | Sscrofa10.2 | 7 | 27,290,516 - 27,293,281 (+) | NCBI | Sscrofa10.2 | Sscrofa10.2 | susScr3 | |
|
PSORS1C2 (Chlorocebus sabaeus - green monkey) |
Green Monkey Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
ChlSab1.1 | 17 | 41,336,262 - 41,339,413 (+) | NCBI | ChlSab1.1 | ChlSab1.1 | chlSab2 | | ChlSab1.1 Ensembl | 17 | 41,337,779 - 41,338,992 (+) | Ensembl | ChlSab1.1 | ChlSab1.1 Ensembl | chlSab2 | | Vero_WHO_p1.0 | NW_023666044 | 30,828,589 - 30,831,049 (-) | NCBI | Vero_WHO_p1.0 | Vero_WHO_p1.0 | | |
|
Psors1c2 (Heterocephalus glaber - naked mole-rat) |
|
.
Predicted Target Of
Count of predictions: | 96 | Count of miRNA genes: | 74 | Interacting mature miRNAs: | 78 | Transcripts: | ENSRNOT00000074958 | Prediction methods: | Microtar, Miranda, Rnahybrid, Targetscan | Result types: | miRGate_prediction |
61472 | Aia1 | Adjuvant induced arthritis QTL 1 | 18 | 0.001 | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 20 | 2646395 | 4597031 | Rat | 2306850 | Pia40 | Pristane induced arthritis QTL 40 | | 0.0001 | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 20 | 1527959 | 5304575 | Rat | 1641915 | Colcr9 | Colorectal carcinoma resistance QTL 9 | 2.97 | 0.0024 | intestine integrity trait (VT:0010554) | benign colorectal tumor number (CMO:0001795) | 20 | 1530655 | 46530655 | Rat | 2317057 | Aia27 | Adjuvant induced arthritis QTL 27 | 2.83 | | joint integrity trait (VT:0010548) | right rear ankle joint diameter (CMO:0002150) | 20 | 2892597 | 26381954 | Rat | 7387283 | Uae44 | Urinary albumin excretion QTL 44 | | 0.1712 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 20 | 1 | 26123605 | Rat | 7411668 | Foco32 | Food consumption QTL 32 | 8 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 20 | 1 | 36600972 | Rat | 2305926 | Iddm37 | Insulin dependent diabetes mellitus QTL 37 | 6 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 20 | 1527842 | 46527842 | Rat | 1354642 | Despr15 | Despair related QTL 15 | | 0.0027 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 20 | 1 | 24159021 | Rat | 1600382 | Edcs3 | Endometrial carcinoma susceptibility QTL3 | 3.5 | 0.003 | uterus morphology trait (VT:0001120) | percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759) | 20 | 1 | 25159026 | Rat | 61448 | Ciaa1 | CIA Autoantibody QTL 1 | 30 | 0.001 | blood autoantibody amount (VT:0003725) | calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) | 20 | 2646395 | 4597031 | Rat | 8694189 | Bw153 | Body weight QTL 153 | 3.13 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 20 | 1 | 29191651 | Rat | 724519 | Bp144 | Blood pressure QTL 144 | | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 20 | 1 | 3624629 | Rat | 9590109 | Sffal8 | Serum free fatty acids level QTL 8 | 5.32 | 0.01 | blood free fatty acid amount (VT:0001553) | plasma free fatty acids level (CMO:0000546) | 20 | 1 | 29191651 | Rat | 9590275 | Scort15 | Serum corticosterone level QTL 15 | 3.48 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 20 | 1 | 29191651 | Rat | 9589155 | Insul32 | Insulin level QTL 32 | 6.38 | 0.001 | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 20 | 1 | 29191651 | Rat | 7411650 | Foco23 | Food consumption QTL 23 | 20.7 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 20 | 1 | 29191651 | Rat | 2317851 | Alcrsp22 | Alcohol response QTL 22 | 3.2 | 0.05 | response to alcohol trait (VT:0010489) | duration of loss of righting reflex (CMO:0002289) | 20 | 1 | 27339237 | Rat | 1598816 | Memor12 | Memory QTL 12 | 2.4 | | exploratory behavior trait (VT:0010471) | average horizontal distance between subject and target during voluntary locomotion in an experimental apparatus (CMO:0002674) | 20 | 2606836 | 47606836 | Rat | 1641893 | Alcrsp7 | Alcohol response QTL 7 | | | response to alcohol trait (VT:0010489) | duration of loss of righting reflex (CMO:0002289) | 20 | 1 | 27339237 | Rat | 6893685 | Bw111 | Body weight QTL 111 | 2.7 | 0.004 | body mass (VT:0001259) | body weight (CMO:0000012) | 20 | 1 | 32578807 | Rat | 9590252 | Scort12 | Serum corticosterone level QTL 12 | 20.46 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 20 | 1 | 36600972 | Rat |
RH132447 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 20 | 3,202,271 - 3,202,451 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 20 | 3,727,517 - 3,727,696 | NCBI | Rnor6.0 | Rnor_5.0 | 20 | 5,814,720 - 5,814,899 | UniSTS | Rnor5.0 | Celera | 20 | 629,435 - 629,614 | UniSTS | | RH 3.4 Map | 20 | 53.13 | UniSTS | | Cytogenetic Map | 20 | p12 | UniSTS | |
|
BI293046 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 20 | 3,205,800 - 3,205,961 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 20 | 3,731,094 - 3,731,254 | NCBI | Rnor6.0 | Rnor_5.0 | 20 | 5,817,836 - 5,817,996 | UniSTS | Rnor5.0 | Celera | 20 | 632,879 - 633,039 | UniSTS | | RH 3.4 Map | 20 | 15.8 | UniSTS | | Cytogenetic Map | 20 | p12 | UniSTS | |
|
alimentary part of gastrointestinal system
| | | | | | | | | | | | | | | |
6
|
1
|
24
|
79
|
43
|
48
|
24
|
12
|
24
|
6
|
97
|
38
|
71
|
28
|
51
|
24
|
Ensembl Acc Id: |
ENSRNOT00000074958 ⟹ ENSRNOP00000064601 |
Type: |
CODING |
Position: |
Rat Assembly | Chr | Position (strand) | Source |
---|
mRatBN7.2 Ensembl | 20 | 3,202,174 - 3,203,599 (-) | Ensembl | Rnor_6.0 Ensembl | 20 | 3,727,419 - 3,728,844 (-) | Ensembl |
|
RefSeq Acc Id: |
NM_001166016 ⟹ NP_001159488 |
RefSeq Status: |
VALIDATED |
Type: |
CODING |
Position: |
Rat Assembly | Chr | Position (strand) | Source |
---|
GRCr8 | 20 | 3,206,886 - 3,208,307 (-) | NCBI | mRatBN7.2 | 20 | 3,202,178 - 3,203,599 (-) | NCBI | Rnor_6.0 | 20 | 3,727,817 - 3,728,805 (-) | NCBI | Rnor_5.0 | 20 | 5,815,020 - 5,816,008 (-) | NCBI | Celera | 20 | 629,735 - 630,723 (-) | RGD |
|
Sequence: |
ATGATGCTCAATTGGAAGCTGCTCGGCCTGCTGGTCCTTTGCCTATTTGCAGGAGGCATCTCAGGCAGTGACGACCCCTCTCCCAAATCCACAGACACCCAAGAAGAGAACTCCCCACCATTGCCTCT GGGACCCCCAATCCCTGGTGATCCCTGGCCAGGGGCACCTCCTCTGTTTGATGAGCCTCCTCCTCCAGGCTCCAACCGTCCCTGGAGAGATCTTCCTGACAGTGGTGCCTGGCCCCCTAAGCCCCCGA GCACTGATCCCCCTAAACCTCCTCTGCCCGATGATCCCTGGCCAGCAGGGACCCAGCCCCCAGAAAATCCCTGGCCTCCTGCCCCTGAGATGGACAGTGAATCTCAGGAGGAGCCAGACCTTGACCCA CCCCGGGAAGAGTATAGATAG
hide sequence
|
RefSeq Acc Id: |
NP_001159488 ⟸ NM_001166016 |
- Peptide Label: |
precursor |
- UniProtKB: |
M0R5D7 (UniProtKB/TrEMBL) |
- Sequence: |
MMLNWKLLGLLVLCLFAGGISGSDDPSPKSTDTQEENSPPLPLGPPIPGDPWPGAPPLFDEPPPPGSNRPWRDLPDSGAWPPKPPSTDPPKPPLPDDPWPAGTQPPENPWPPAPEMDSESQEEPDLDP PREEYR
hide sequence
|
|
Ensembl Acc Id: |
ENSRNOP00000064601 ⟸ ENSRNOT00000074958 |
|
RGD ID: | 13701311 |
Promoter ID: | EPDNEW_R11835 |
Type: | single initiation site |
Name: | Psors1c2_1 |
Description: | psoriasis susceptibility 1 candidate 2 |
SO ACC ID: | SO:0000170 |
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) |
Experiment Methods: | Single-end sequencing. |
Position: | Rat Assembly | Chr | Position (strand) | Source |
---|
Rnor_6.0 | 20 | 3,728,844 - 3,728,904 | EPDNEW |
|
Date |
Current Symbol |
Current Name |
Previous Symbol |
Previous Name |
Description |
Reference |
Status |
2016-08-29 |
Psors1c2 |
psoriasis susceptibility 1 candidate 2 |
Psors1c2 |
psoriasis susceptibility 1 candidate 2 (human) |
Nomenclature updated to reflect human and mouse nomenclature |
1299863 |
APPROVED |
2011-10-31 |
Psors1c2 |
psoriasis susceptibility 1 candidate 2 (human) |
LOC686254 |
similar to Psoriasis susceptibility 1 candidate gene 2 protein homolog precursor (SPR1 protein) |
Data merged from RGD:1584310 |
737654 |
APPROVED |
2006-11-20 |
Psors1c2 |
psoriasis susceptibility 1 candidate 2 (human) |
|
|
Symbol and Name status set to provisional |
70820 |
PROVISIONAL |
2006-11-19 |
LOC686254 |
similar to Psoriasis susceptibility 1 candidate gene 2 protein homolog precursor (SPR1 protein) |
|
|
Symbol and Name status set to provisional |
70820 |
PROVISIONAL |
|
|